Gaeta A - Search Results

1

Molina-Holgado F, Hider RC, Gaeta A, Williams R, Francis P. Molina-Holgado F, et al. Among authors: gaeta a. Biometals. 2007 Jun;20(3-4):639-54. doi: 10.1007/s10534-006-9033-z. Epub 2007 Feb 9. Biometals. 2007. PMID: 17294125 Review.

2

The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy.

Gaeta A, Hider RC. Gaeta A, et al. Br J Pharmacol. 2005 Dec;146(8):1041-59. doi: 10.1038/sj.bjp.0706416. Br J Pharmacol. 2005. PMID: 16205720 Free PMC article. Review.

3

Iron chelation as a potential therapy for neurodegenerative disease.

Hider RC, Ma Y, Molina-Holgado F, Gaeta A, Roy S. Hider RC, et al. Among authors: gaeta a. Biochem Soc Trans. 2008 Dec;36(Pt 6):1304-8. doi: 10.1042/BST0361304. Biochem Soc Trans. 2008. PMID: 19021545 Review.

4

Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells.

Molina-Holgado F, Gaeta A, Francis PT, Williams RJ, Hider RC. Molina-Holgado F, et al. Among authors: gaeta a. J Neurochem. 2008 Jun 1;105(6):2466-76. doi: 10.1111/j.1471-4159.2008.05332.x. J Neurochem. 2008. PMID: 18331585 Free article.

5

Synthesis, physical-chemical characterisation and biological evaluation of novel 2-amido-3-hydroxypyridin-4(1H)-ones: Iron chelators with the potential for treating Alzheimer's disease.

Gaeta A, Molina-Holgado F, Kong XL, Salvage S, Fakih S, Francis PT, Williams RJ, Hider RC. Gaeta A, et al. Bioorg Med Chem. 2011 Feb 1;19(3):1285-97. doi: 10.1016/j.bmc.2010.12.007. Epub 2010 Dec 13. Bioorg Med Chem. 2011. PMID: 21236688

6

Synthesis and anti-tubercular evaluation of 4-quinolylhydrazones.

Savini L, Chiasserini L, Gaeta A, Pellerano C. Savini L, et al. Among authors: gaeta a. Bioorg Med Chem. 2002 Jul;10(7):2193-8. doi: 10.1016/s0968-0896(02)00071-8. Bioorg Med Chem. 2002. PMID: 11983516

7

The development of potential new fluorine-18 labelled radiotracers for imaging the GABA(A) receptor.

Jackson A, Guilbert BB, Plant SD, Goggi J, Battle MR, Woodcraft JL, Gaeta A, Jones CL, Bouvet DR, Jones PA, O'Shea DM, Zheng PH, Brown SL, Ewan AL, Trigg W. Jackson A, et al. Among authors: gaeta a. Bioorg Med Chem Lett. 2013 Feb 1;23(3):821-6. doi: 10.1016/j.bmcl.2012.11.066. Epub 2012 Nov 28. Bioorg Med Chem Lett. 2013. PMID: 23265897

8

Development of molecular probes for the identification of extra interaction sites in the mid-gorge and peripheral sites of butyrylcholinesterase (BuChE). Rational design of novel, selective, and highly potent BuChE inhibitors.

Campiani G, Fattorusso C, Butini S, Gaeta A, Agnusdei M, Gemma S, Persico M, Catalanotti B, Savini L, Nacci V, Novellino E, Holloway HW, Greig NH, Belinskaya T, Fedorko JM, Saxena A. Campiani G, et al. Among authors: gaeta a. J Med Chem. 2005 Mar 24;48(6):1919-29. doi: 10.1021/jm049510k. J Med Chem. 2005. PMID: 15771436

9

Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors.

Savini L, Gaeta A, Fattorusso C, Catalanotti B, Campiani G, Chiasserini L, Pellerano C, Novellino E, McKissic D, Saxena A. Savini L, et al. Among authors: gaeta a. J Med Chem. 2003 Jan 2;46(1):1-4. doi: 10.1021/jm0255668. J Med Chem. 2003. PMID: 12502352

10

Use of 2-[(18)F]fluoroethylazide for the Staudinger ligation - Preparation and characterisation of GABA(A) receptor binding 4-quinolones.

Gaeta A, Woodcraft J, Plant S, Goggi J, Jones P, Battle M, Trigg W, Luthra SK, Glaser M. Gaeta A, et al. Bioorg Med Chem Lett. 2010 Aug 1;20(15):4649-52. doi: 10.1016/j.bmcl.2010.05.106. Epub 2010 Jun 8. Bioorg Med Chem Lett. 2010. PMID: 20579877

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

354 results

Search Page